Vision-based assessment of parkinsonism and levodopa-induced dyskinesia with pose estimation
- PMID: 30400914
- PMCID: PMC6219082
- DOI: 10.1186/s12984-018-0446-z
Vision-based assessment of parkinsonism and levodopa-induced dyskinesia with pose estimation
Abstract
Background: Despite the effectiveness of levodopa for treatment of Parkinson's disease (PD), prolonged usage leads to development of motor complications, most notably levodopa-induced dyskinesia (LID). Persons with PD and their physicians must regularly modify treatment regimens and timing for optimal relief of symptoms. While standardized clinical rating scales exist for assessing the severity of PD symptoms, they must be administered by a trained medical professional and are inherently subjective. Computer vision is an attractive, non-contact, potential solution for automated assessment of PD, made possible by recent advances in computational power and deep learning algorithms. The objective of this paper was to evaluate the feasibility of vision-based assessment of parkinsonism and LID using pose estimation.
Methods: Nine participants with PD and LID completed a levodopa infusion protocol, where symptoms were assessed at regular intervals using the Unified Dyskinesia Rating Scale (UDysRS) and Unified Parkinson's Disease Rating Scale (UPDRS). Movement trajectories of individual joints were extracted from videos of PD assessment using Convolutional Pose Machines, a pose estimation algorithm built with deep learning. Features of the movement trajectories (e.g. kinematic, frequency) were used to train random forests to detect and estimate the severity of parkinsonism and LID. Communication and drinking tasks were used to assess LID, while leg agility and toe tapping tasks were used to assess parkinsonism. Feature sets from tasks were also combined to predict total UDysRS and UPDRS Part III scores.
Results: For LID, the communication task yielded the best results (detection: AUC = 0.930, severity estimation: r = 0.661). For parkinsonism, leg agility had better results for severity estimation (r = 0.618), while toe tapping was better for detection (AUC = 0.773). UDysRS and UPDRS Part III scores were predicted with r = 0.741 and 0.530, respectively.
Conclusion: The proposed system provides insight into the potential of computer vision and deep learning for clinical application in PD and demonstrates promising performance for the future translation of deep learning to PD clinical practices. Convenient and objective assessment of PD symptoms will facilitate more frequent touchpoints between patients and clinicians, leading to better tailoring of treatment and quality of care.
Keywords: Computer vision; Deep learning; Levodopa-induced dyskinesia; Parkinsonism; Pose estimation.
Conflict of interest statement
Ethics approval and consent to participate
This study was approved by the University Health Network Research Ethics Board and written informed consent was provided by all participants.
Consent for publication
Not applicable.
Competing interests
In the preceding 12 months, SH Fox has received:
TA Mestre has received:
MH Li and B Taati have no competing interests to disclose.
Publisher’s Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Figures
Similar articles
-
Automated assessment of levodopa-induced dyskinesia: Evaluating the responsiveness of video-based features.Parkinsonism Relat Disord. 2018 Aug;53:42-45. doi: 10.1016/j.parkreldis.2018.04.036. Epub 2018 May 5. Parkinsonism Relat Disord. 2018. PMID: 29748112
-
Automated vision-based analysis of levodopa-induced dyskinesia with deep learning.Annu Int Conf IEEE Eng Med Biol Soc. 2017 Jul;2017:3377-3380. doi: 10.1109/EMBC.2017.8037580. Annu Int Conf IEEE Eng Med Biol Soc. 2017. PMID: 29060621
-
Quantitative assessment of levodopa-induced dyskinesia using automated motion sensing technology.Annu Int Conf IEEE Eng Med Biol Soc. 2012;2012:154-7. doi: 10.1109/EMBC.2012.6345894. Annu Int Conf IEEE Eng Med Biol Soc. 2012. PMID: 23365855 Clinical Trial.
-
Levodopa-induced dyskinesia in Parkinson's disease: epidemiology, etiology, and treatment.Curr Neurol Neurosci Rep. 2007 Jul;7(4):302-10. doi: 10.1007/s11910-007-0046-y. Curr Neurol Neurosci Rep. 2007. PMID: 17618536 Review.
-
Safety and Efficacy of Levetiracetam for the Management of Levodopa- Induced Dyskinesia in Patients with Parkinson's Disease: A Systematic Review.CNS Neurol Disord Drug Targets. 2019;18(4):317-325. doi: 10.2174/1871527318666190314101314. CNS Neurol Disord Drug Targets. 2019. PMID: 30868968
Cited by
-
Toward an Automatic System for Computer-Aided Assessment in Facial Palsy.Facial Plast Surg Aesthet Med. 2020 Jan/Feb;22(1):42-49. doi: 10.1089/fpsam.2019.29000.gua. Facial Plast Surg Aesthet Med. 2020. PMID: 32053425 Free PMC article.
-
Multimodal Classification of Parkinson's Disease in Home Environments with Resiliency to Missing Modalities.Sensors (Basel). 2021 Jun 16;21(12):4133. doi: 10.3390/s21124133. Sensors (Basel). 2021. PMID: 34208690 Free PMC article.
-
WM-STGCN: A Novel Spatiotemporal Modeling Method for Parkinsonian Gait Recognition.Sensors (Basel). 2023 May 22;23(10):4980. doi: 10.3390/s23104980. Sensors (Basel). 2023. PMID: 37430892 Free PMC article.
-
A Graph-Theoretic Approach to Detection of Parkinsonian Freezing of Gait From Videos.Stat Med. 2025 Feb 28;44(5):e70020. doi: 10.1002/sim.70020. Stat Med. 2025. PMID: 39976295 Free PMC article.
-
Review-Emerging Portable Technologies for Gait Analysis in Neurological Disorders.Front Hum Neurosci. 2022 Feb 3;16:768575. doi: 10.3389/fnhum.2022.768575. eCollection 2022. Front Hum Neurosci. 2022. PMID: 35185496 Free PMC article. Review.
References
-
- Statistics on Parkinson’s - Parkinson’s Disease Foundation (PDF). [cited 2017 Mar 28]. Available from: http://parkinson.org/Understanding-Parkinsons/Causes-and-Statistics/Stat....
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical